Публикуван на 14.06.2020 г.
Pharma giant AstraZeneca struck a deal Saturday with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental Covid-19 vaccine, as efforts to boost manufacturing capacity continue at pace.
Subscribe to France 24 now:
FRANCE 24 live news stream: all the latest news 24/7
Visit our website:
Subscribe to our YouTube channel:
Like us on Facebook:
Follow us on Twitter: